Corrigendum to "Simvastatin attenuates macrophage-mediated gemcitabine resistance of pancreatic ductal adenocarcinoma by regulating the TGF-β1/Gfi-1" [Canc. Lett. 385 (2017) 65–74]. (1st August 2022)

Record Type:: Journal Article
Title:: Corrigendum to "Simvastatin attenuates macrophage-mediated gemcitabine resistance of pancreatic ductal adenocarcinoma by regulating the TGF-β1/Gfi-1" [Canc. Lett. 385 (2017) 65–74]. (1st August 2022)
Main Title:: Corrigendum to "Simvastatin attenuates macrophage-mediated gemcitabine resistance of pancreatic ductal adenocarcinoma by regulating the TGF-β1/Gfi-1" [Canc. Lett. 385 (2017) 65–74]
Authors:: Xian, Guozhe
Zhao, Juan
Qin, Chengkun
Zhang, Zhenhai
Lin, Yanliang
Su, Zhongxue
Abstract:
Is Part Of:: Cancer letters. Volume 540(2022)
Journal:: Cancer letters
Issue:: Volume 540(2022)
Issue Display:: Volume 540, Issue 2022 (2022)
Year:: 2022
Volume:: 540
Issue:: 2022
Issue Sort Value:: 2022-0540-2022-0000
Page Start:
Page End:
Publication Date:: 2022-08-01
Subjects:: Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Electronic journals
616.994
Journal URLs:: http://www.sciencedirect.com/science/journal/03043835/ ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.canlet.2022.215739 ↗
Languages:: English
ISSNs:: 0304-3835
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3046.485000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 21566.xml